Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups

Nat Rev Rheumatol. 2024 May;20(5):313-314. doi: 10.1038/s41584-024-01106-8.

Thomas Khoo^{1

2

3}, James B Lilleker^{1

4}, Bernard Yu-Hor Thong⁵, Valérie Leclair⁶, Janine A Lamb⁷, Hector Chinoy^{8

9}

¹ Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
² School of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
³ Department of Rheumatology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK.
⁴ Manchester Centre for Clinical Neuroscience, Manchester Academic Health Science Centre, Salford Royal Hospital, Northern Care Alliance, NHS Foundation Trust, Salford, UK.
⁵ Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore.
⁶ Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada.
⁷ Epidemiology and Public Health Group, School of Health Sciences, The University of Manchester, Manchester, UK.
⁸ Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. hector.chinoy@manchester.ac.uk.
⁹ Department of Rheumatology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK. hector.chinoy@manchester.ac.uk.

No abstract available

Publication types